Venture Certified
| 벤처투자유형 | 2020-10-22 ~ 2022-10-21 | 20200301201 | 2020-10-22 |
| 벤처투자유형 | 2022-10-22 ~ 2025-10-21 | 20221005010013 | 2020-10-22 |
| 벤처투자유형 | 2025-10-22 ~ 2028-10-21 | 20250909010017 | 2020-10-22 |
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 0.0B | 0.0B | 0.0B |
| Operating Profit | -25.1B | -24.2B | -21.6B |
| Net Profit | -22.4B | -17.8B | -21.6B |
| Total Assets | 38.0B | 26.9B | 43.7B |
| Total Liabilities | 23.4B | 9.8B | 8.8B |
| Total Equity | 14.6B | 17.1B | 34.9B |
Operating Loss: Op. profit -25B
3 Consecutive Years of Net Loss
Debt Ratio Surge (+102pp YoY)
▲ 0.0%
▼ 9.7%
▲ 286.0%
▼ 84.0%
| Name | Position | Role |
|---|---|---|
| 김원종 | 대표이사 | 대표 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "경상북도 포항시",
"ceo_name": "김원종",
"certificate": [
{
"cert_number": "20200301201",
"changes": "",
"disclosure_date": "2020-10-22",
"first_cert_date": "2020-10-22",
"no": "1",
"type": "벤처투자유형",
"valid_period": "2020-10-22 ~ 2022-10-21"
},
{
"cert_number": "20221005010013",
"changes": "",
"disclosure_date": "2022-10-05",
"first_cert_date": "2020-10-22",
"no": "2",
"type": "벤처투자유형",
"valid_period": "2022-10-22 ~ 2025-10-21"
},
{
"cert_number": "20250909010017",
"changes": "",
"disclosure_date": "2025-09-09",
"first_cert_date": "2020-10-22",
"no": "3",
"type": "벤처투자유형",
"valid_period": "2025-10-22 ~ 2028-10-21"
}
],
"company_name": "(주)옴니아 메드",
"corp_no": "171711-*******",
"financials": {
"2022": {
"capital_stock": 86457000,
"cost_of_sales": 0,
"current_assets": 3071310000,
"current_liabilities": 818388000,
"gross_profit": 0,
"net_income": -2161953000,
"net_income_bs": -2161953000,
"non_current_assets": 1294396000,
"non_current_liabilities": 59362000,
"non_operating_expenses": 11450000,
"non_operating_income": 8277000,
"operating_profit": -2158780000,
"revenue": 0,
"sga_expenses": 2158780000,
"total_assets": 4365706000,
"total_equity": 3487956000,
"total_liabilities": 877750000
},
"2023": {
"capital_stock": 86457000,
"cost_of_sales": 0,
"current_assets": 1636383000,
"current_liabilities": 823796000,
"gross_profit": 0,
"net_income": -1781550000,
"net_income_bs": -1781550000,
"non_current_assets": 1053941000,
"non_current_liabilities": 160122000,
"non_operating_expenses": 31554000,
"non_operating_income": 667589000,
"operating_profit": -2417585000,
"revenue": 0,
"sga_expenses": 2417585000,
"total_assets": 2690324000,
"total_equity": 1706406000,
"total_liabilities": 983918000
},
"2024": {
"capital_stock": 93514000,
"cost_of_sales": 0,
"current_assets": 3401250000,
"current_liabilities": 2130811000,
"gross_profit": 3200000,
"net_income": -2240224000,
"net_income_bs": -2240224000,
"non_current_assets": 401843000,
"non_current_liabilities": 208650000,
"non_operating_expenses": 399328000,
"non_operating_income": 669235000,
"operating_profit": -2510131000,
"revenue": 3200000,
"sga_expenses": 2513331000,
"total_assets": 3803093000,
"total_equity": 1463632000,
"total_liabilities": 2339461000
}
},
"industry": "물리, 화학 및 생물학 연구개발업",
"investment": [
{
"amount": "200,080,400",
"changes": "200,080,400",
"date": "2024-12-20"
},
{
"amount": "5,000,000,000",
"changes": "5,000,000,000",
"date": "2022-08-28"
},
{
"amount": "1,500,000,000",
"changes": "1,500,000,000",
"date": "2022-08-26"
},
{
"amount": "1,500,036,200",
"changes": "1,500,036,200",
"date": "2022-08-26"
},
{
"amount": "3,000,137,000",
"changes": "3,000,137,000",
"date": "2020-08-28"
}
],
"main_products": "NO의 기능을 활용한 신약개발 기술연구",
"phone": "054-279-****",
"years": [
2024,
2023,
2022
]
}Data Quality: 8/10 | Primary Source: Venture System | Section Coverage: 7/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | Public Data | Collected |
| Financial Statements | Venture System | Collected |
| Investment Metrics | Venture System | Collected |
| Officers | Public Data | Collected |
| Employment | Not Collected | Not Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| G2B Procurement | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Cert. Info | 2026-02-25 | Collected |
| Venture System Detail | 2026-02-25 | Collected |